Biliary Tract Cancer Guidelines Excel at Clarity but Leave Precision Oncology Pathways Incomplete
A systematic review of 27 guideline families using AGREE II and AGREE-REX finds that clinical practice guidelines for precision oncology ...
Tag: biliary tract cancer
Immunotherapy Boost for Bile Duct Cancer Survival Holds Firm After Three Years
Three-year follow-up of the phase 3 KEYNOTE-966 trial confirms that adding pembrolizumab to gemcitabine and cisplatin chemotherapy maintains a durable ...
Immune Cells Feed Breast Cancer Tumors as AI and DNA Testing Reshape Cancer Care
New MSK studies reveal that immune cells secretly feed triple-negative breast cancer, a CXCR2 blocker sensitizes leptomeningeal metastases to radiation, ...
New Trial Tests Oral Drug Plus Nanoliposomal Irinotecan for Hard-to-Treat Bile Duct Cancer
A German phase II trial called TRITICC-2 is testing whether oral trifluridine/tipiracil combined with nanoliposomal irinotecan can improve outcomes for ...
Peanut Root Compound Shows Promise Against Inflammation-Driven Bile Duct Cancer
A Thai research team reports that an arachidin-rich extract from peanut hairy root cultures suppresses inflammation-driven molecular events linked to ...
Breast Cancer History Emerges as Striking Signal in Gallbladder Cancer Patients
A two-cohort study of 1,687 biliary tract cancer patients found that a prior breast cancer diagnosis was significantly more prevalent ...
CD39 Emerges as a Deadly Biomarker and Drug Target in Bile Duct Cancer
New research shows that the immune enzyme CD39 is overexpressed in cholangiocarcinoma, drives tumor growth and metastasis through the ANXA2 ...
Most Biliary Tract Cancer Patients in China Miss Guideline-Recommended Immunotherapy, Survey Finds
A nationwide survey of 120 Chinese physicians reveals that most patients with advanced biliary tract cancer never receive guideline-recommended immunotherapy ...
New Expert Consensus Maps the Safety Minefield of HER2-Guided Cancer Drugs in Digestive Tumors
A new Chinese expert consensus provides detailed, evidence-graded guidance for managing the hematologic, gastrointestinal, pulmonary, hepatic, neurologic, and ocular side ...
Epigenetic Boost Fails to Awaken Immune Therapy in Bile Duct Cancer Trial
A phase 2 trial found that the HDAC inhibitor entinostat combined with nivolumab produced no tumor responses in advanced cholangiocarcinoma, ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!